Skip to contentSkip to navigation

Molecular detection of Influenza A/B and Respiratory Syncytial Virus (RSV)

The use of nucleic acid amplification techniques (PCR) allows very rapid and reliable detection of influenza A and B viruses and respiratory syncytial virus (RSV). The analysis is performed on the same specimen by swabbing secretions from the upper respiratory tract.

Traditional techniques, which consist of antigen detection (EIA), make it possible to identify some of the viruses responsible for respiratory symptoms. These EIA tests can detect 50-70% of influenza cases, but only 30% of RSV infections. When the clinical need indicates it, it is therefore necessary to confirm negative results by a more efficient technique in order to propose appropriate treatments and protective measures.

Biron sets itself apart

Molecular detection of Influenza A/B and Respiratory Syncytial Virus (RSV)*.

  • Detection of Influenza A/B and RSV from the same sample.
  • Same-day results available.**
  • Avoids unnecessary use of antibiotic.
  • Accelerates medical care.
  • Costs reimbursed by most insurers.

*A doctor's prescription is required.
**Depending on the time of receipt of the sample.

Term of the Week

Predictive medicine

Medicine that links medical knowledge with data to predict a patient’s potential health problems. Examples include artificial intelligence and genetics.